Moderna, Inc. is a company in the U.S. stock market and it is a holding in 62 U.S.-traded ETFs. MRNA has around 16.3M shares in the U.S. ETF market. The largest ETF holder of MRNA is the iShares NASDAQ Biotechnology ETF (IBB), with approximately 3.13M shares. Investors may also find of interest that the ETF with the largest allocation to MRNA stock is Loncar Cancer Immunotherapy ETF (CNCR), with a portfolio weight of 10.04%. On average, U.S. ETFs allocate 1.06% of MRNA to their portfolios.
Additionally, MRNA is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with MRNA as a holding is the Virtus LifeSci Biotech Clinical Trials ETF (BBC), with a return of 27.53%.